548 related articles for article (PubMed ID: 26995367)
1. Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
Golwala H; Jackson LR; Simon DN; Piccini JP; Gersh B; Go AS; Hylek EM; Kowey PR; Mahaffey KW; Thomas L; Fonarow GC; Peterson ED; Thomas KL;
Am Heart J; 2016 Apr; 174():29-36. PubMed ID: 26995367
[TBL] [Abstract][Full Text] [Related]
2. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.
Essien UR; Holmes DN; Jackson LR; Fonarow GC; Mahaffey KW; Reiffel JA; Steinberg BA; Allen LA; Chan PS; Freeman JV; Blanco RG; Pieper KS; Piccini JP; Peterson ED; Singer DE
JAMA Cardiol; 2018 Dec; 3(12):1174-1182. PubMed ID: 30484833
[TBL] [Abstract][Full Text] [Related]
3. Racial and ethnic differences in the prevalence, management, and outcomes in patients with atrial fibrillation: A systematic review.
Ugowe FE; Jackson LR; Thomas KL
Heart Rhythm; 2018 Sep; 15(9):1337-1345. PubMed ID: 29803022
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Quality of Anticoagulation Therapy for Atrial Fibrillation (from the TREAT-AF Study).
Yong C; Azarbal F; Abnousi F; Heidenreich PA; Schmitt S; Fan J; Than CT; Ullal AJ; Yang F; Phibbs CS; Frayne SM; Ho PM; Shore S; Mahaffey KW; Turakhia MP
Am J Cardiol; 2016 Jan; 117(1):61-8. PubMed ID: 26552504
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
6. Association of Race and Ethnicity With Oral Anticoagulation and Associated Outcomes in Patients With Atrial Fibrillation: Findings From the Get With The Guidelines-Atrial Fibrillation Registry.
Essien UR; Chiswell K; Kaltenbach LA; Wang TY; Fonarow GC; Thomas KL; Turakhia MP; Benjamin EJ; Rodriguez F; Fang MC; Magnani JW; Yancy CW; Piccini JP
JAMA Cardiol; 2022 Dec; 7(12):1207-1217. PubMed ID: 36287545
[TBL] [Abstract][Full Text] [Related]
7. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
[TBL] [Abstract][Full Text] [Related]
8. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
9. Patient Diversity and Population Health-Related Cardiovascular Outcomes Associated with Warfarin Use in Atrial Fibrillation: An Analysis Using Administrative Claims Data.
Kim MH; Xu L; Puckrein G
Adv Ther; 2018 Nov; 35(11):2069-2080. PubMed ID: 30219991
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and cardiovascular outcomes in patients with atrial fibrillation receiving rhythm-control therapy: the Fushimi AF Registry.
An Y; Esato M; Ishii M; Iguchi M; Masunaga N; Tsuji H; Wada H; Hasegawa K; Ogawa H; Abe M; Lip GYH; Akao M
Heart Vessels; 2018 Dec; 33(12):1534-1546. PubMed ID: 29797059
[TBL] [Abstract][Full Text] [Related]
11. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study.
Potpara TS; Polovina MM; Marinkovic JM; Lip GY
Int J Cardiol; 2013 Oct; 168(5):4744-9. PubMed ID: 23958417
[TBL] [Abstract][Full Text] [Related]
12. Effect of race on outcomes (stroke and death) in patients >65 years with atrial fibrillation.
Kabra R; Cram P; Girotra S; Vaughan Sarrazin M
Am J Cardiol; 2015 Jul; 116(2):230-5. PubMed ID: 26004053
[TBL] [Abstract][Full Text] [Related]
13. Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).
Cherian TS; Shrader P; Fonarow GC; Allen LA; Piccini JP; Peterson ED; Thomas L; Kowey PR; Gersh BJ; Mahaffey KW
Am J Cardiol; 2017 Jun; 119(11):1763-1769. PubMed ID: 28416199
[TBL] [Abstract][Full Text] [Related]
14. Oral Anticoagulation for Stroke Prevention in Canadian Practice: Stroke Prevention and Rhythm Interventions in Atrial Fibrillation (SPRINT-AF) Registry(.).
Ha AC; Singh N; Cox JL; Mancini GB; Dorian P; Fournier C; Gladstone DJ; Lockwood E; Shuaib A; Kajil M; Tsigoulis M; Gupta MK
Can J Cardiol; 2016 Feb; 32(2):204-10. PubMed ID: 26195228
[TBL] [Abstract][Full Text] [Related]
15. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation.
Shen AY; Chen W; Yao JF; Brar SS; Wang X; Go AS
CNS Drugs; 2008; 22(10):815-25. PubMed ID: 18788834
[TBL] [Abstract][Full Text] [Related]
16. Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
Pokorney SD; Simon DN; Thomas L; Fonarow GC; Kowey PR; Chang P; Singer DE; Ansell J; Blanco RG; Gersh B; Mahaffey KW; Hylek EM; Go AS; Piccini JP; Peterson ED;
Am Heart J; 2015 Jul; 170(1):141-8, 148.e1. PubMed ID: 26093875
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Nonagenarians With Atrial Fibrillation: Insights From the Berlin Atrial Fibrillation (BAF) Registry.
Wutzler A; von Ulmenstein S; Attanasio P; Huemer M; Parwani AS; Boldt LH; Haverkamp W
J Am Med Dir Assoc; 2015 Nov; 16(11):969-72. PubMed ID: 26123257
[TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
O'Neal WT; Tanner RM; Efird JT; Baber U; Alonso A; Howard VJ; Howard G; Muntner P; Soliman EZ
Int J Cardiol; 2015 Apr; 185():219-23. PubMed ID: 25797681
[TBL] [Abstract][Full Text] [Related]
19. [Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry].
De Caterina R; Renda G; Sangiuolo R; Attena E; Di Lecce L; Romeo F;
G Ital Cardiol (Rome); 2014 Feb; 15(2):99-109. PubMed ID: 24625849
[TBL] [Abstract][Full Text] [Related]
20. Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry).
Thind M; Holmes DN; Badri M; Pieper KS; Singh A; Blanco RG; Steinberg BA; Fonarow GC; Gersh BJ; Mahaffey KW; Peterson ED; Reiffel JA; Piccini JP; Kowey PR;
Am J Cardiol; 2018 Nov; 122(10):1677-1683. PubMed ID: 30227964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
